The reproductive effects of beta interferon therapy for multiple sclerosis.

被引：0
|
作者：
Boskovic, R [1 ]
Wade, R [1 ]
Koren, G [1 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.12.004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P29 / P29
页数：1
相关论文
共 50 条
  • [1] The reproductive effects of beta interferon therapy for multiple sclerosis
    不详
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2005, 73 (05) : 298 - 298
  • [2] Interferon therapy for multiple sclerosis. A question of the right dose?
    Hohlfeld, R
    NERVENARZT, 2001, 72 (02): : 67 - 68
  • [3] Multiple sclerosis - Side effects of interferon beta therapy and their management
    Walther, EU
    Hohlfeld, R
    NEUROLOGY, 1999, 53 (08) : 1622 - 1627
  • [4] Neutralising Antibodies to Interferon-beta Therapy in Chinese Patients with Relapsing and Remitting Multiple Sclerosis.
    Ip, W. K.
    Lau, A. Y. L.
    Zhang, S.
    Au, C. C. K.
    Wong, W.
    Lau, K. K.
    Li, P.
    Chan, E. Y. T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 416 - 417
  • [5] Depression and treatment with interferon beta-1b in multiple sclerosis.
    Weinstein, A
    Schwid, S
    Goodman, A
    Petrie, M
    Giang, D
    Schiffer, R
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 146 - 147
  • [6] Biomarkers of Interferon Beta Therapy in Multiple Sclerosis
    Graber, Jerome J.
    Dhib-Jalbut, Suhayl
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2014, 34 (08): : 600 - 604
  • [7] Beta Interferon Protein Therapy for Multiple Sclerosis
    Farooque, Alma
    Huettl, Maggie
    Kaiser, Jennifer
    Shukla, Neehal
    Van Oudenhoven, Quinn
    Dopp, Amy
    Rolak, Loren
    FASEB JOURNAL, 2013, 27
  • [8] Rare Side effects of Therapy with Interferon-beta in Multiple Sclerosis
    Hohlfeld, I
    Simon, J. C.
    Wetzig, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 205 - 205
  • [9] Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
    Jacobs, LD
    Beck, RW
    Simon, JH
    Kinkel, RP
    Brownscheidle, CM
    Murray, TJ
    Simonian, NA
    Slasor, PJ
    Sandrock, AW
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13): : 898 - 904
  • [10] Cutaneous vasculitis with renal impairment complicating interferon-beta 1a therapy for multiple sclerosis.
    Zoguéreh, DD
    Boucraut, J
    Beau-Salinas, F
    Bodiguel, E
    Lechapois, D
    Pomet, E
    REVUE NEUROLOGIQUE, 2004, 160 (11) : 1081 - 1084
12345